GlobalData on MSN18d
Sage rejects Biogen’s $469m takeover bidSage’s board of directors said that the proposal “significantly undervalues” the company and is not in the best interest of shareholders.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback